Withdrawal Notice
This paper was originally published in Oncotarget Advance Online Publications on 01/13/2018.In compliance with Oncotarget's withdrawal policy, the paper was withdrawn in its entirety. It will not appear in Oncotarget internal or any external indexes or archives.
Research Papers:
DNA methylation and gene expression of matrix metalloproteinase-9 gene in Deficit and Non-Deficit Schizophrenia
Ju Gao1,2,*, Hongwei Yi3,*, Xiaowei Tang4,*, Xiaotang Feng5, Miao Yu1, Weiwei Sha4, Xiang Wang6, Xiaobin Zhang4 and Xiangrong Zhang1,7
1 Department of Geriatric Psychiatry, Affiliated Nanjing Brain Hospital, Nanjing Medical University, Nanjing, Jiangsu, China
2 Centers of Disease Prevention and Control for Mental Disorders, Shanghai Changning Mental Health Center, Shanghai, China
3 Department of Neuropsychiatry, Affiliated ZhongDa Hospital and School of Medical, Southeast University, Nanjing, Jiangsu, China
4 Department of Psychiatry, Affiliated WuTaiShan Hospital of Medical College of Yangzhou University, Yangzhou, Jiangsu, China
5 Department of Psychiatry, Nanjing Qing Long Mountain Psychiatric Hospital, Nanjing, Jiangsu, China
6 Medical Psychological Institute of the Second Xiangya Hospital, Central South University, Changsha, Hunan, China
7 Neurologic Department of Affiliated ZhongDa Hospital, Neuropsychiatric Institute and Medical School of Southeast University, Nanjing, Jiangsu, China
*These authors have contributed equally to this work
Correspondence to:
Xiangrong Zhang, email: [email protected]
Keywords: defective schizophrenia; matrix metalloproteinase-9; DNA methylation; gene expression; negative symptoms
Received: July 31, 2017 Accepted: December 05, 2017 Epub: January 13, 2018
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 24223